[go: up one dir, main page]

SK46993A3 - New heterocyclic compounds as antagonists of excitatory amino acid receptors, process for their preparation and their use - Google Patents

New heterocyclic compounds as antagonists of excitatory amino acid receptors, process for their preparation and their use Download PDF

Info

Publication number
SK46993A3
SK46993A3 SK46993A SK46993A SK46993A3 SK 46993 A3 SK46993 A3 SK 46993A3 SK 46993 A SK46993 A SK 46993A SK 46993 A SK46993 A SK 46993A SK 46993 A3 SK46993 A3 SK 46993A3
Authority
SK
Slovakia
Prior art keywords
group
compounds
methylene
formula
carbon atoms
Prior art date
Application number
SK46993A
Other languages
English (en)
Slovak (sk)
Inventor
Alf Claesson
Britt-Marie Swahn
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK46993A3 publication Critical patent/SK46993A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Injection Moulding Of Plastics Or The Like (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK46993A 1990-11-15 1991-11-07 New heterocyclic compounds as antagonists of excitatory amino acid receptors, process for their preparation and their use SK46993A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003652A SE9003652D0 (sv) 1990-11-15 1990-11-15 New heterocyclic compounds
PCT/SE1991/000753 WO1992008724A1 (fr) 1990-11-15 1991-11-07 Nouveaux composes heterocycliques utilises comme antagonistes de recepteurs d'acide amine excitateurs, procedes servant a leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
SK46993A3 true SK46993A3 (en) 1993-10-06

Family

ID=20380925

Family Applications (1)

Application Number Title Priority Date Filing Date
SK46993A SK46993A3 (en) 1990-11-15 1991-11-07 New heterocyclic compounds as antagonists of excitatory amino acid receptors, process for their preparation and their use

Country Status (17)

Country Link
EP (1) EP0557375A1 (fr)
JP (1) JPH06502421A (fr)
CN (1) CN1061595A (fr)
AU (1) AU652399B2 (fr)
CA (1) CA2095224A1 (fr)
CZ (1) CZ80993A3 (fr)
FI (1) FI932206A7 (fr)
HU (1) HU9301417D0 (fr)
IE (1) IE913922A1 (fr)
IS (1) IS3782A7 (fr)
LT (1) LTIP1718A (fr)
MX (1) MX9101979A (fr)
NO (1) NO931679L (fr)
PT (1) PT99515A (fr)
SE (1) SE9003652D0 (fr)
SK (1) SK46993A3 (fr)
WO (1) WO1992008724A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
TW281670B (fr) * 1993-09-02 1996-07-21 Hoffmann La Roche
US5491241A (en) * 1993-10-18 1996-02-13 Eli Lilly And Company Bicyclic intermediates for excitatory amino acid receptor antagonists
DK3984994T3 (da) 2016-02-04 2024-10-14 Takeda Pharmaceuticals Co Substitueret piperidinforbindelse som orexin-type 2-agonist til behandling af narkolepsi

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques
JPS612519A (ja) * 1984-04-24 1986-01-08 Aron Kasei Co Ltd 射出成形法
US4906621A (en) * 1985-05-24 1990-03-06 Ciba-Geigy Corporation Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
US4740346A (en) * 1986-02-26 1988-04-26 The Budd Company Perimeter resin feeding of composite structures
JPS63112129A (ja) * 1986-10-30 1988-05-17 Toyoda Gosei Co Ltd 多色樹脂成形用金型
IL84492A0 (en) * 1986-11-21 1988-04-29 Ciba Geigy Ag Unsaturated phosphonic acids and derivatives

Also Published As

Publication number Publication date
FI932206L (fi) 1993-05-14
EP0557375A1 (fr) 1993-09-01
MX9101979A (es) 1992-07-08
FI932206A0 (fi) 1993-05-14
IS3782A7 (is) 1992-05-16
WO1992008724A1 (fr) 1992-05-29
IE913922A1 (en) 1992-05-20
AU8939191A (en) 1992-06-11
JPH06502421A (ja) 1994-03-17
HU9301417D0 (en) 1993-09-28
NO931679D0 (no) 1993-05-07
SE9003652D0 (sv) 1990-11-15
CZ80993A3 (en) 1994-02-16
LTIP1718A (en) 1995-07-25
NO931679L (no) 1993-05-07
CN1061595A (zh) 1992-06-03
CA2095224A1 (fr) 1992-05-16
PT99515A (pt) 1992-09-30
AU652399B2 (en) 1994-08-25
FI932206A7 (fi) 1993-05-14

Similar Documents

Publication Publication Date Title
AT393384B (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
EP0272208B1 (fr) Acides azacycloalkylalcanediphosphoniques substitués aromatiquement
SI9111099A (sl) Postopek za pripravo aralifatsko N-substituiranih aminoalkanfosfinskih kislin
HUT53879A (en) Improved process for producing decahydro-isoquinoline derivatives
EP0539057B1 (fr) Acides benzimidazole phosphono-aminés
DE69014697T2 (de) Tetrahydrobenz[c,d]indole als Serotonin-Agonisten.
EP0569333B1 (fr) Nouveaux acides N-aralkyl et N-hétéroaralkylamino alcane phosphoniques
DE3510858A1 (de) Substituierte (alpha)-aminosaeuren, verfahren zu deren herstellung und diese enthaltende arzneimittel
Hays et al. New and versatile approaches to the synthesis of CPP-related competitive NMDA antagonists. Preliminary structure activity relationships and pharmacological evaluation
SK46993A3 (en) New heterocyclic compounds as antagonists of excitatory amino acid receptors, process for their preparation and their use
EP0389425B1 (fr) Benzothiopyranylamines
EP0420806B1 (fr) Acides phosphoniques, procédé de préparation et utilisation comme composition pharmaceutique
US5489717A (en) Glutamate (NMDA) receptor antagonists
US5710139A (en) Heterocyclic compounds
DE69015745T2 (de) NMDA-Antagonisten.
DE69115116T2 (de) Heterocyclische NMDA Antagonisten.
DE69310524T2 (de) Phosphono substituierte tetrazol-derivate
US5500419A (en) NMDA antagonists
EP0213080A2 (fr) Dérivés hydrogénés de la pyridine
JPH02196723A (ja) リン含有酵素阻害剤